Amicus Therapeutics, Inc.
FOLDDelisted Apr 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178879
Amicus Therapeutics, Inc. was delisted on Apr 27, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 298 institutions reported holding it in 13F filings for Q1 2026, worth $4.81B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in Amicus Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 213
- +1 vs. Q1 2022
- Shares held
- 305.2M
- +2.06M (+0.7%) vs. Q1 2022
- Total value
- $3.28B
- +$406.6M (+14.2%) vs. Q1 2022
- New holders
- 28
- 67 more added
- Sold out
- 27
- 78 more reduced
4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FOLD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $11.5K |
| Q1 2026 | 298 | $4.81B |
| Q4 2025 | 332 | $4.57B |
| Q3 2025 | 287 | $2.46B |
| Q2 2025 | 272 | $1.83B |
| Q1 2025 | 286 | $2.55B |
| Q4 2024 | 290 | $2.88B |
| Q3 2024 | 293 | $3.31B |
| Q2 2024 | 259 | $3.13B |
| Q1 2024 | 254 | $3.79B |
| Q4 2023 | 229 | $4.53B |
| Q3 2023 | 229 | $3.63B |
| Q2 2023 | 216 | $3.86B |
| Q1 2023 | 226 | $3.30B |
| Q4 2022 | 230 | $3.57B |
| Q3 2022 | 222 | $3.05B |
| Q2 2022 | 213 | $3.28B |
| Q1 2022 | 216 | $2.87B |
| Q4 2021 | 224 | $3.48B |
| Q3 2021 | 238 | $2.80B |
| Q2 2021 | 235 | $2.67B |
| Q1 2021 | 259 | $2.74B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Amicus Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Macquarie Group Ltd | 6,767,246 | $72.7M | 0.08% | +224,367+3.4% | Added |
| Palo Alto Investors LP | 9,847,774 | $105.8M | 9.22% | −55,987−0.6% | Reduced |
| Wellington Management Group LLP | 11,024,744 | $118.4M | 0.02% | −15,594,363−58.6% | Reduced |
| State Street Corp | 13,918,315 | $149.5M | 0.01% | +1,983,752+16.6% | Added |
| JPMorgan Chase & Co | 15,864,107 | $170.4M | 0.03% | +312,291+2.0% | Added |
| Janus Henderson Group PLC | 16,780,141 | $180.2M | 0.12% | +1,157,528+7.4% | Added |
| Morgan Stanley | 18,313,580 | $196.7M | 0.03% | +1,092,228+6.3% | Added |
| BlackRock Inc. | 20,249,858 | $217.5M | 0.01% | +656,857+3.4% | Added |
| Redmile Group, LLC | 22,158,891 | $238.0M | 9.09% | −170,495−0.8% | Reduced |
| Vanguard Group Inc | 25,732,089 | $276.4M | 0.01% | +74,919+0.3% | Added |
| Avoro Capital Advisors LLC | 26,800,000 | $287.8M | 5.69% | +6,300,000+30.7% | Added |
| Perceptive Advisors LLC | 26,895,532 | $288.9M | 9.08% | −660,313−2.4% | Reduced |
| International Biotechnology Trust PLC | 1,017 | – | – | −93,583−98.9% | Reduced |
| Woodline Partners LP | 0 | $0 | 0.00% | −864,282−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −100,110−100.0% | Sold out |
| Longitude (Cayman) Ltd. | 0 | $0 | 0.00% | −74,000−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −38,608−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −32,921−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −29,448−100.0% | Sold out |
| Laurel Wealth Advisors, Inc. | 0 | $0 | 0.00% | −25,656−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −24,651−100.0% | Sold out |
| Jupiter Asset Management Ltd | 0 | $0 | 0.00% | −23,300−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −20,371−100.0% | Sold out |
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −12,783−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −12,685−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −12,095−100.0% | Sold out |
| Fulton Bank, N.A. | 0 | $0 | 0.00% | −10,523−100.0% | Sold out |
| CIBC Asset Management Inc | 0 | $0 | 0.00% | −10,064−100.0% | Sold out |
| Neo Ivy Capital Management | 0 | $0 | 0.00% | −3,318−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,788−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| Concord Wealth Partners | 0 | $0 | 0.00% | −685−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −416−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Kayne Anderson Rudnick Investment Management LLC | 0 | $0 | 0.00% | −223−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −94−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −42−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| TCWP LLC | 0 | $0 | 0.00% | −86−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |
| Virginia Retirement Systems Et Al | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |